Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
23-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #37169
advertisement
Yang J
34
Showing records 1 to 25 |
Display all abstracts from
Yang J
106119
Structure‒function‒pathogenicity analysis of C-terminal myocilin missense variants based on experiments and 3D models
Zhou B
Frontiers in genetics
2022; 13: 1019208
106340
Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Sun X
Ophthalmology and therapy
2023; 12: 341-353
106140
Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Hao H
Biomaterials advances
2022; 142: 213162
105500
Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies
Shen WC
Neural Regeneration Research
2023; 18: 87-93
106226
Stereoscopic vs. monoscopic photographs on optic disc evaluation and glaucoma diagnosis among general ophthalmologists: A cloud-based real-world multicenter study
Yang J
Frontiers in medicine
2022; 9: 990611
106134
Clinical Efficacy of Topical Tacrolimus on Conjunctival Hyperemia Caused by Prostaglandin Analogues
Yang J
Evidence-based Complementary and Alternative Medicine
2022; 2022: 3700720
106140
Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Hao H
Biomaterials advances
2022; 142: 213162
106226
Stereoscopic vs. monoscopic photographs on optic disc evaluation and glaucoma diagnosis among general ophthalmologists: A cloud-based real-world multicenter study
Qu Y
Frontiers in medicine
2022; 9: 990611
106134
Clinical Efficacy of Topical Tacrolimus on Conjunctival Hyperemia Caused by Prostaglandin Analogues
Shi Y
Evidence-based Complementary and Alternative Medicine
2022; 2022: 3700720
106340
Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Yao K
Ophthalmology and therapy
2023; 12: 341-353
106140
Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
He B
Biomaterials advances
2022; 142: 213162
106119
Structure‒function‒pathogenicity analysis of C-terminal myocilin missense variants based on experiments and 3D models
Lin X
Frontiers in genetics
2022; 13: 1019208
105500
Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies
Huang BQ
Neural Regeneration Research
2023; 18: 87-93
106119
Structure‒function‒pathogenicity analysis of C-terminal myocilin missense variants based on experiments and 3D models
Li Z
Frontiers in genetics
2022; 13: 1019208
106340
Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Liu Q
Ophthalmology and therapy
2023; 12: 341-353
105500
Regulatory mechanisms of retinal ganglion cell death in normal tension glaucoma and potential therapies
Yang J
Neural Regeneration Research
2023; 18: 87-93
106134
Clinical Efficacy of Topical Tacrolimus on Conjunctival Hyperemia Caused by Prostaglandin Analogues
Chen H
Evidence-based Complementary and Alternative Medicine
2022; 2022: 3700720
106140
Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Yu B
Biomaterials advances
2022; 142: 213162
106226
Stereoscopic vs. monoscopic photographs on optic disc evaluation and glaucoma diagnosis among general ophthalmologists: A cloud-based real-world multicenter study
Zhao J; Cong J
Frontiers in medicine
2022; 9: 990611
106119
Structure‒function‒pathogenicity analysis of C-terminal myocilin missense variants based on experiments and 3D models
Yao Y
Frontiers in genetics
2022; 13: 1019208
106140
Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Yang J
Biomaterials advances
2022; 142: 213162
106340
Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Zhang H
Ophthalmology and therapy
2023; 12: 341-353
106140
Suprachoroidal injection of polyzwitterion hydrogel for treating glaucoma
Xing X
Biomaterials advances
2022; 142: 213162
106226
Stereoscopic vs. monoscopic photographs on optic disc evaluation and glaucoma diagnosis among general ophthalmologists: A cloud-based real-world multicenter study
Sun Z
Frontiers in medicine
2022; 9: 990611
106340
Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
Xing X
Ophthalmology and therapy
2023; 12: 341-353
«
1
2
»
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement